Skip to main content

Pharma News

 

Clinical courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Mirum’s LIVMARLI now Authorized in Canada for Cholestatic Pruritus

    Mirum Pharmaceuticals, Inc announced that LIVMARLI® (maralixibat oral solution) has been authorized by Health Canada for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS).

  • Jardiance (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease

    The European Commission (EC) approved Jardiance (empagliflozin) for the treatment of adults with chronic kidney disease (CKD), Boehringer Ingelheim and Eli Lilly and Company announced today.

  • AstraZeneca Pharma receives approval for Dapagliflozin from DCGI

    AstraZeneca Pharma India Limited has received Permission to import pharmaceutical formulations of new drug for sale or for distribution in Form CT-20 from the Drugs Controller General of India for Dapagliflozin Tablets 10 mg.

    Dapagliflozin Tablets 10mg is indicated for the treatment of heart failure in adults. Forxiga (dapagliflozin) was developed by Bristol-Myers Squibb and AstraZeneca. It belongs to a class of drugs known as SGLT2 (sodium-glucose cotransporter 2) inhibitors.

  • WHO releases new guidance to improve testing and diagnosis of sexually transmitted infections

    The World Health Organization (WHO) is sharing its latest guidance on sexually transmitted infections (STI) at the STI & HIV 2023 World Congress taking place in Chicago, the United States of America, on 24-27 July 2023. With STIs on the rise, WHO is calling for better access to testing and diagnostic services. At the congress, WHO will also discuss its latest STI research agenda and antimicrobial resistance (AMR) in gonorrhoea.

  • Orexo’s patent win for ZUBSOLV appealed

    Orexo AB announces that Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, Sun Pharma Global, Inc., and Sun Pharmaceutical Industries, Inc have appealed the patent litigation decision issued by the US District Court for the District of New Jersey relating to Orexo’s patents protecting ZUBSOLV  (buprenorphine and naloxone) sublingual tablets (CIII) in the US.

  • Eugia Pharma receives USFDA approval for Plerixafor Injection

    Aurobindo Pharma Limited is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and commercializes a wide range of generic pharmaceuticals, branded specialty pharmaceuticals and active pharmaceutical ingredients globally in over 150 countries.

  • Cosmohome Tech Expo 2023

    Cosmohome Tech Expo was held in Delhi at Pragati Maidan from 19th to21st July 2023. It was its 9th edition, comprising of 350+ Exhibitors to display latest Ingredients, Formulations, Fragrances, Packaging, Instruments & Machinery, Labelling, Contract Manufacturing.

  • Is MSW online possible after Pharmacy degree?

    Yes, it is possible for individuals with a pharmacy background to pursue a Master's in Social Work (MSW) online. While it may not be the most common pathway, people from diverse educational backgrounds are often welcomed in the field of social work. And this course (after pharmacy) is for someone who wants to opt-out from pharmacy or explore other career options that are offered after a pharmacy degree.

  • Biotech StartUps are crucial to Indias future economy

    Union Minister of State (Independent Charge) for Science and Technology, MoS PMO, Department of Atomic Energy and Department of Space and MoS Personnel, Public Grievances and Pensions, Dr Jitendra Singh has said that the Biotech StartUps are crucial to India’s future economy.

  • New study shows anti-inflammatory drugs as a promising target for Alzheimer’s disease

    A recent study from the lab of the University of Kentucky’s Sanders-Brown Center on Aging Director Linda Van Eldik, Ph.D., has been published in PLOS ONE. The work centers around the idea that various anti-inflammatory drugs could be effective treatments for Alzheimer’s disease (AD). This study focused on a protein known as p38. Many labs have been working with this protein as a potential target for drug development to treat Alzheimer’s disease and other conditions with neuroinflammatory dysfunction.

Subscribe to Pharma News